Cargando…
OR07-2 Endocrine Response And Resistance Is Driven By Novel Transcriptional Co-Regulator Activity In Invasive Lobular Carcinoma Of The Breast
Invasive lobular carcinoma of the breast (ILC) affects ∼40,000 US women annually and is a top ten most diagnosed cancer in women. ∼95% of ILC express estrogen receptor alpha (ER), but ILC is associated with poor long-term outcomes and anti-estrogen resistance, suggesting ER function is distinct in I...
Autores principales: | Costello, James, Danis, Etienne, Goodspeed, Andrew, Mohammed, Hisham, Sottnik, Joseph, Sikora, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706628/ http://dx.doi.org/10.1210/jendso/bvac150.1489 |
Ejemplares similares
-
OR12-05 MDC1 Is a Novel Estrogen Receptor Co-Regulator in Invasive Lobular Carcinoma of the Breast
por: Bordeaux, Evelyn K, et al.
Publicado: (2020) -
OR09-1 Estrogen Drives Atypical Cell-autonomous WNT4 Signaling In Lobular Carcinoma
por: Ferguson, Rebecca, et al.
Publicado: (2019) -
OR07-5 PARP1 Contributes to the Glucocorticoid Receptor Transcriptional Response And Influences the Skeletal Muscle Phenotype
por: Boocock, David, et al.
Publicado: (2022) -
RF03 | PMON289 KLF4 drives estrogen driven tumor heterogeneity in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2022) -
OR07-3 Hormone-Controlled Cooperative Binding of Transcription Factors Within Enhancer Clusters Drives Synergistic Induction of Fasting-Regulated Genes
por: Charni-Natan, Meital, et al.
Publicado: (2022)